Pazienteen bihotz eta arnasketa maiztasunen monitorizazioa burmuineko infragorri hurbileko espektroskopia seinaleak erabiliz

Lan honen helburua, burmuineko oxigeno maila neurtzeko NIRS (Near Infrarred Spectroscopy) teknika ez-inbaditzaileaz baliatzen den sistema baten eraginkortasuna neurtzea da, pazientearen parametro fisiologikoak diren bihotz eta arnasketa maiztasunak neurtzerako orduan. Orain arte, pazientearen oxigenazioaren monitorizazioa gauzatzea beharrezkoa den egoeratan, atzamarreko oxigenazio maila neurtzea ahalbidetzen duen PPG (Photoplethysmogram) teknika erabili da. Emergentzia egoeratan, ordea, sistema kardiobaskularrak bizi irauteko nahitaezkoak diren organoei ematen die lehentasuna, garuna eta bihotzari, alegia. Bi organo hauek oxigeno jario jarraituaz hornituak direla egiaztatzeko, ezinbestekoa izango da burmuineko oxigenazio maila neurtzea eta berriki frogatu da NIRS teknikak esparru honetan etorkizun handiko emaitzak eskaini ditzakeela. Hau dela eta, azken urteotan, NIRS teknikak lekua hartu dio orain arte agertoki mediku gehienetan erabilitako PPG teknikari, gaur egun teknika hau aplikazio ugaritan erabiltzen hasia delarik, adibidez kirurgia kardiobaskularraren monitorizazioa edo anestesia orokorraren bitarteko monitorizazioa. NIRS teknikak, garuneko oxigenazio mailaz aparte, pazientearen beste hainbat parametro fisiologikoren neurketa ahalbidetuko balu (arnasketa eta bihotz maiztasuna), agertoki mediku asko erraztuko lituzke, gailu bakar batekin pazientearen bizi-konstante anitzen monitorizazio eramango baitzen aurrera. Tresna hau egingarria dela egiaztatzeko, lehenik eta behin, NIRS seinalea bizi-konstante hauen berri emateko gai dela balioetsi behar da eta hauxe da, hain zuzen, proiektu honen xede nagusia. Azken helburu hau lortzeko, hainbat azpi-helburu proposatzen dira hemen aurkeztuko den proiektuan: lehenik eta behin, NIRS seinaleak eta bizi konstante hauek era fidagarrian lortzea ahalbidetzen duten seinaleak biltegiratzen dituen datu base bat sortuko da. Datu base hau osatzeko, aurreko seinale guztiak aldi berean eskuratuko dituen neurketa sistema sinkrono bat sortzea ezinbestekoa izango da eta azkenik, NIRS seinaleen eraginkortasuna ebaluatzeko, seinaleen prozesaketan oinarritutako hainbat algoritmo garatuko dira.

Determination of drugs used in combined cardiovascular therapy

Cardiovascular diseases are nowadays the first cause of mortality worldwide, causing around the 30% of global deaths each year. The risk of suffering from cardiovascular illnesses is strongly related to some factors such as hypertension, high cholesterol levels, diabetes, obesity The combination of these different risk factors is known as metabolic syndrome and it is considered a pandemic due to the high prevalence worldwide. The pathology of the disorders implies a combined cardiovascular therapy with drugs which have different targets and mechanisms of action, to regulate each factor separately. The simultaneous analysis of these drugs turns interesting but it is a complex task since the determination of multiple substances with different physicochemical properties and physiological behavior is always a challenge for the analytical chemist. The complexity of the biological matrices and the difference in the expected concentrations of some analytes require the development of extremely sensitive and selective determination methods. The aim of this work is to fill the gap existing in this field of the drug analysis, developing analytical methods capable of quantifying the different drugs prescribed in combined cardiovascular therapy simultaneously. Liquid chromatography andem mass spectrometry (LCMS/MS) has been the technique of choice throughout the main part of this work, due to the high sensitivity and selectivity requirements.

Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk

Background: Vitamin K has been related to glucose metabolism, insulin sensitivity and diabetes. Because inflammation underlies all these metabolic conditions, it is plausible that the potential role of vitamin K in glucose metabolism occurs through the modulation of cytokines and related molecules. The purpose of the study was to assess the associations between dietary intake of vitamin K and peripheral adipokines and other metabolic risk markers related to insulin resistance and type 2 diabetes mellitus. Methods: Cross-sectional and longitudinal assessments of these associations in 510 elderly participants recruited in the PREDIMED centers of Reus and Barcelona (Spain). We determined 1-year changes in dietary phylloquinone intake estimated by food frequency questionnaires, serum inflammatory cytokines and other metabolic risk markers. Results: In the cross-sectional analysis at baseline no significant associations were found between dietary phylloquinone intake and the rest of metabolic risk markers evaluated, with exception of a negative association with plasminogen activator inhibitor-1. After 1-year of follow-up, subjects in the upper tertile of changes in dietary phylloquinone intake showed a greater reduction in ghrelin (-15.0%), glucose-dependent insulinotropic peptide (-12.9%), glucagon-like peptide-1 (-17.6%), IL-6 (-27.9%), leptin (-10.3%), TNF (-26.9%) and visfatin (-24.9%) plasma concentrations than those in the lowest tertile (all p<0.05). Conclusion: These results show that dietary phylloquinone intake is associated with an improvement of cytokines and other markers related to insulin resistance and diabetes, thus extending the potential protection by dietary phylloquinone on chronic inflammatory diseases.

Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery

Background: Non-alcoholic fatty liver disease (NAFLD) is caused by abnormal accumulation of lipids within liver cells. Its prevalence is increasing in developed countries in association with obesity, and it represents a risk factor for non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. Since NAFLD is usually asymptomatic at diagnosis, new non-invasive approaches are needed to determine the hepatic lipid content in terms of diagnosis, treatment and control of disease progression. Here, we investigated the potential of magnetic resonance imaging (MRI) to quantitate and monitor the hepatic triglyceride concentration in humans. Methods: A prospective study of diagnostic accuracy was conducted among 129 consecutive adult patients (97 obesity and 32 non-obese) to compare multi-echo MRI fat fraction, grade of steatosis estimated by histopathology, and biochemical measurement of hepatic triglyceride concentration (that is, Folch value). Results: MRI fat fraction positively correlates with the grade of steatosis estimated on a 0 to 3 scale by histopathology. However, this correlation value was stronger when MRI fat fraction was linked to the Folch value, resulting in a novel equation to predict the hepatic triglyceride concentration (mg of triglycerides/g of liver tissue = 5.082 + (432.104 * multi-echo MRI fat fraction)). Validation of this formula in 31 additional patients (24 obese and 7 controls) resulted in robust correlation between the measured and estimated Folch values. Multivariate analysis showed that none of the variables investigated improves the Folch prediction capacity of the equation. Obese patients show increased steatosis compared to controls using MRI fat fraction and Folch value. Bariatric surgery improved MRI fat fraction values and the Folch value estimated in obese patients one year after surgery. Conclusions: Multi-echo MRI is an accurate approach to determine the hepatic lipid concentration by using our novel equation, representing an economic non-invasive method to diagnose and monitor steatosis in humans.

Valoración del riesgo cardiovascular y edad vascular en personas con hipertensión primaria

INTRODUCCIÓN: los factores de riesgo cardiovasculares (FRCV) son los que se asocian a una mayor probabilidad de sufrir una enfermedad cardiovascular (ECV), estos pueden ser no modificables o modificables como la hipertensión primaria que tiene un origen multifactorial. Mediante el método Framingham se describen el perfil del riesgo cardiovascular absoluto (RCV) que es la probabilidad de presentar un evento cardiovascular en 10 años y la edad vascular (EV) la cual indica la edad que le corresponde a las arterias. OBJETIVOS: 1) Estimar el perfil de RCV y EV en personas con HTA primaria a través del método Framingham. 2) Conocer dentro del RCV, si el riesgo es bajo, medio o alto teniendo en cuenta la edad, HDL-colesterol, colesterol total (COL), pensión arterial sistólica (PAS), diabetes tipo 1 y tipo 2 y el tabaquismo. MÉTODOS: participaron en el estudio 58 personas (edad= 51,7 ±7,8 años) 46 hombres y 12 mujeres) diagnosticadas con HTA primaria y sobrepeso u obesidad, incluidas en la investigación EXERDIET-HTA. Se les realizó una estimación del RCV y EV a través del método Framingham. Las variables que se consideraron para la valoración fueron la edad, HDL-C, COL, PAS, si padecían diabetes o no y si eran fumadores o no. RESULTADOS: las personas estudiadas presentan un RCV del 15,5±7,7% que se relaciona con un RCV de nivel medio, siendo más alto en los hombres que en las mujeres (P=0,001). En la totalidad el 24% de los participantes presenta un RCV alto, el 47% medio y el 24% bajo. La EV media estimada es de 65±10 años, 13 años superior a la edad cronológica. CONCLUSIONES: Personas con diagnóstico de HTA primaria y el correspondiente tratamiento farmacológico presentan un RCV medio a sufrir un evento cardiovascular en los próximos 10 años de entre el 10-20%. Se hace necesario un control más exhaustivo de todos los FRCV, de forma especial en los hombres en relación con el hábito del tabaquismo. La EV en personas hipertensas es superior a la edad cronológica, lo que acentúa la necesidad de adopción de un estilo de vida más saludable